Cellvizio by Mauna Kea Technologies

Cellvizio by Mauna Kea Technologies Cellvizio is the real-time in vivo cellular imaging platform that revolutionizes the way physicians

Mauna Kea Technologies is a global medical device company that manufactures and sells Cellvizio®, the real-time in vivo cellular imaging platform. This technology uniquely delivers in vivo cellular visualization which enables physicians to monitor the progression of disease over time, assess point-in-time reactions as they happen in real-time, classify indeterminate areas of concern, and guide sur

gical interventions. The Cellvizio platform is used globally across a wide range of medical specialties and is revolutionizing the way physicians diagnose and treat patients — making a transformative change in medicine.

in action at Centro Médico Teknon in Barcelona! Differentiating pancreatic cyst types is critical to patient outcomes....
09/04/2026

in action at Centro Médico Teknon in Barcelona! Differentiating pancreatic cyst types is critical to patient outcomes. Dr. Gonzalo Lopez and his team recently performed procedures where made a decisive difference. Kudos for leveraging cutting-edge technology to drive real clinical impact!

09/03/2026

With a focus on reducing unnecessary procedures and enhancing patient outcomes, integrates into any healthcare system and paves the way for more precise, effective healthcare.

Know the latest updates on nCLE in Pancreatic Cysts: https://hubs.la/Q04wysD60

-Neil Sharma, MD FACG, FASGE, AGAF

08/26/2026

A landmark systematic review and meta-analysis published in Endoscopy International Open, conducted and funded by Korea's National Evidence-Based Healthcare Collaborating Agency (NECA), delivers massive clinical validation for in upper GI cancer! Pooling data across 33 studies and 2,350 patients, the evidence proves that real-time cellular imaging dramatically sharpens diagnostic accuracy while cutting unnecessary tissue sampling.

When independent, gold-standard evidence confirms both clinical efficacy and efficiency, it's a win for physicians, payers, and most importantly, patients.

Real the full PR: https://hubs.la/Q04vrv9p0

08/25/2026

Conventional imaging and fluid analysis for often leave physicians in the dark, leading to misdiagnosis or unnecessary, high-risk surgeries. As highlighted in this study, needle-based Confocal Laser Endomicroscopy ( ) using AI enables more precise clinical decision-making, ensuring that surgical interventions are reserved for those who truly need them.

Read the full publication: https://hubs.la/Q04vbqbH0

Somashekar Krishna
Almed Abdelbaki
Tassiana Maloof
Steve Serrao, M.D, FACP

Heading to the Windy City! Cellvizio by Mauna Kea Technologies will be in attendance this Friday at Chicago Live 2026 at...
08/20/2026

Heading to the Windy City! Cellvizio by Mauna Kea Technologies will be in attendance this Friday at Chicago Live 2026 at Northwestern Memorial Hospital.

As GI specialists, and endoscopy professionals gather to discuss the forefront of , we’re ready to demonstrate how is driving the conversation on transforming patient outcomes. See you in Chicago!

08/20/2026

Exciting developments in pancreatic cyst diagnostics! When combining with traditional methods, diagnostic accuracy soars. This kind of precision is transforming how we approach patient care.

Learn more: https://hubs.la/Q04txWpQ0

Neil Sharma, MD FACG, FASGE, AGAF

08/19/2026

Members of our Cellvizio by Mauna Kea Technologies team will be attending Florida Live Endoscopy 2026 this week, hosted by the Orlando Health Digestive Health Institute.

We look forward to connecting with pioneers driving the next generation of endoscopic care. If you'll be in attendance, we would love to connect with you to discuss the latest advancements in and its impact on patient care.

Will we see you there? Let us know in the comments or send us a message to connect! https://hubs.la/Q04ty5L20

08/13/2026

Pancreatic cysts: a diagnostic puzzle. With conflicting guidelines, clarity is elusive. Enter novel tech like , offering new hope for accurate diagnosis and management.

Insights from Neil Sharma, MD FACG, FASGE, AGAF.

Learn more: https://hubs.la/Q04sVNHq0

08/06/2026

Dr. Somashekar Krishna and his team published landmark research in Pancreatology, demonstrating that combined with AI significantly outperforms human experts in risk stratification of pancreatic cysts (IPMNs). Combined with validated CLIMB study data from Digestive Disease Week® (DDW®), the evidence is clear: Cellvizio delivers unmatched accuracy in pancreatic cyst diagnosis. We're driving the future of precision medicine to improve patient outcomes.

Learn more about this breakthrough: https://hubs.la/Q04rF-4B0

Elsevier

Address

24 Denby Road, Suite 140
Boston, MA
02134

Opening Hours

Monday 8:30am - 5pm
Tuesday 8:30am - 5pm
Wednesday 8:30am - 5pm
Thursday 8:30am - 5pm
Friday 8:30am - 5pm

Website

Alerts

Be the first to know and let us send you an email when Cellvizio by Mauna Kea Technologies posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.

Shortcuts

Share